EPS Bio Technology Corp.

TPEX:4183 Stock Report

Market Cap: NT$556.9m

EPS Bio Technology Past Earnings Performance

Past criteria checks 5/6

EPS Bio Technology has been growing earnings at an average annual rate of 0.6%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 0.5% per year. EPS Bio Technology's return on equity is 11.1%, and it has net margins of 6.9%.

Key information

0.6%

Earnings growth rate

0.6%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate0.5%
Return on equity11.1%
Net Margin6.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)

Apr 16
Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)

Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?

Mar 20
Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?

Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative

Feb 22
Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative

Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?

Feb 01
Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?

Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?

Jan 04
Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?

Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?

Dec 14
Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?

We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential

Nov 23
We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential

Revenue & Expenses Breakdown

How EPS Bio Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4183 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24498346034
31 Mar 24477306033
31 Dec 23470215833
30 Sep 23424205432
30 Jun 23454245732
31 Mar 23442255531
31 Dec 22463256131
30 Sep 22506366031
30 Jun 22485255931
31 Mar 22504265931
31 Dec 21480195532
30 Sep 2145175432
30 Jun 21435155532
31 Mar 21459225732
31 Dec 20478326030
30 Sep 20497346032
30 Jun 20489286033
31 Mar 20466195833
31 Dec 19459185533
30 Sep 19437335532
30 Jun 19443315332
31 Mar 19445415232
31 Dec 18414165431
30 Sep 18431135230
30 Jun 1840495329
31 Mar 18390-125529
31 Dec 1742035430
30 Sep 1743426733
30 Jun 1745346934
31 Mar 17466276034
31 Dec 16467296634
30 Sep 16420185533
30 Jun 16426335232
31 Mar 16416245930
31 Dec 15425375030
30 Sep 15426295232
30 Jun 1541975534
31 Mar 15372-135636
31 Dec 14324-335637
30 Sep 14339-265637
30 Jun 14353-185537
31 Mar 14369-45337
31 Dec 1338495136

Quality Earnings: 4183 has high quality earnings.

Growing Profit Margin: 4183's current net profit margins (6.9%) are higher than last year (5.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4183's earnings have grown by 0.6% per year over the past 5 years.

Accelerating Growth: 4183's earnings growth over the past year (39.5%) exceeds its 5-year average (0.6% per year).

Earnings vs Industry: 4183 earnings growth over the past year (39.5%) exceeded the Medical Equipment industry 3.5%.


Return on Equity

High ROE: 4183's Return on Equity (11.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies